188 related articles for article (PubMed ID: 27572116)
1. In vitro inhibition of cytochrome P-450 activities and quantification of constituents in a selection of commercial Rhodiola rosea products.
Thu OK; Nilsen OG; Hellum B
Pharm Biol; 2016 Dec; 54(12):3249-3256. PubMed ID: 27572116
[TBL] [Abstract][Full Text] [Related]
2. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans.
Thu OK; Spigset O; Nilsen OG; Hellum B
Eur J Clin Pharmacol; 2016 Mar; 72(3):295-300. PubMed ID: 26613955
[TBL] [Abstract][Full Text] [Related]
3. The authenticity and quality of Rhodiola rosea products.
Booker A; Jalil B; Frommenwiler D; Reich E; Zhai L; Kulic Z; Heinrich M
Phytomedicine; 2016 Jun; 23(7):754-62. PubMed ID: 26626192
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 inhibition activities of non-standardized botanical products.
Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
[TBL] [Abstract][Full Text] [Related]
5. Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product.
Thu OKF; Spigset O; Hellum B
Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805981
[TBL] [Abstract][Full Text] [Related]
6. Two potent cytochrome P450 2D6 inhibitors found in Rhodiola rosea.
Xu W; Zhang T; Wang Z; Liu T; Liu Y; Cao Z; Sui Z
Pharmazie; 2013 Dec; 68(12):974-6. PubMed ID: 24400445
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming-evoked oxidative stress in the rat.
Huang SC; Lee FT; Kuo TY; Yang JH; Chien CT
Chin J Physiol; 2009 Oct; 52(5):316-24. PubMed ID: 20034236
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Quality and Potential Efficacy of Commercial Extracts of
Dimpfel W; Schombert L; Panossian AG
Front Pharmacol; 2018; 9():425. PubMed ID: 29881348
[No Abstract] [Full Text] [Related]
10. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea.
Hellum BH; Tosse A; Hoybakk K; Thomsen M; Rohloff J; Georg Nilsen O
Planta Med; 2010 Mar; 76(4):331-8. PubMed ID: 19790032
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of TRAIL on mouse T cells via ERK phosphorylation by Rhodiola rosea L. and its marker compounds.
Marchev AS; Dimitrova P; Koycheva IK; Georgiev MI
Food Chem Toxicol; 2017 Oct; 108(Pt B):419-428. PubMed ID: 28189478
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
13. Phenolic Compounds of
Bernatoniene J; Jakstas V; Kopustinskiene DM
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569669
[TBL] [Abstract][Full Text] [Related]
14. Phenylpropanoid glycosides from Rhodiola rosea.
Tolonen A; Pakonen M; Hohtola A; Jalonen J
Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):467-70. PubMed ID: 12673010
[TBL] [Abstract][Full Text] [Related]
15. Rapid resolution liquid chromatography (RRLC) analysis for quality control of Rhodiola rosea roots and commercial standardized products.
Ma YC; Wang XQ; Hou FF; Ma J; Luo M; Lu S; Jin P; Terevsky N; Chen A; Xu I; Patel AV; Gorecki D
Nat Prod Commun; 2011 May; 6(5):645-50. PubMed ID: 21615025
[TBL] [Abstract][Full Text] [Related]
16. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice.
Perfumi M; Mattioli L
Phytother Res; 2007 Jan; 21(1):37-43. PubMed ID: 17072830
[TBL] [Abstract][Full Text] [Related]
17. A supercritical fluid workflow for the quality assessment of herbal drugs and commercial preparations from Rhodiola rosea.
Langeder J; Grienke U
Phytochem Anal; 2021 Nov; 32(6):982-991. PubMed ID: 33638206
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
19. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine.
Zhao Y; Hellum BH; Liang A; Nilsen OG
Phytother Res; 2012 Feb; 26(2):277-83. PubMed ID: 21678521
[TBL] [Abstract][Full Text] [Related]
20. Aloe vera juice: IC₅₀ and dual mechanistic inhibition of CYP3A4 and CYP2D6.
Djuv A; Nilsen OG
Phytother Res; 2012 Mar; 26(3):445-51. PubMed ID: 21842479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
